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Pseudoangiosarcomatous carcinoma of the genitourinary tract
Pathological findings
The bladder showed diffuse thickening ofmost
of its wall by infiltrating haemorrhagic tumour.
Microscopically, the tumour was predomin-
antly a typical high grade transitional cell car-
cinoma showing focal keratinisation. In the
deeper aspect there was a spindle cell and
pseudoangiosarcomatous pattern similar to
that seen in case 1, with cystic and slit-like
spaces lined by tumour cells (fig 2). These were
also negative for factor VIII, QBEND 1 0, JC70,
and S100 protein, but positive for Cam 5-2
and AE1/3 (fig 2).
Lymph nodes examined contained meta-
static tumour which also had a pseudo-
angiosarcomatous pattern.
Discussion
Sarcomas of the vulva and bladder are rare
and are predominantly leiomyosarcomas and
malignant fibrous histiocytomas.6' Angio-
sarcomas are exceedingly rare with only oc-
casional cases reported.6 While examples of
so called spindle cell or pseudosarcomatous
carcinoma of the female genital tract and blad-
der have been described,' 2 no case of pseudo-
angiosarcomatous carcinoma has, to our know-
ledge, been reported at these sites. Banerjee et
al3 studied seven cases from skin, breast and
lung, four of which were originally diagnosed
as angiosarcoma, and Nappi et al45 reported a
small series from the skin and lung. The correct
diagnosis was established by a combination of
a careful search for focal keratinisation and
atypical squamous epithelium, immuno-
histochemistry and ultrastructural analysis. In
our cases the tumours had similar mor-
phological features to those described by Baner-
jee et al and Nappi et al, the diagnoses being
confirmed by the presence of focal ker-
atinisation and a vascular marker negative,
cytokeratin positive immunophenotype.
It has been suggested that acantholysis is the
underlying pathogenic mechanism,3 possibly as
a consequence ofchanges in adhesion molecule
expression by the tumour cells. There is evi-
dence ofreduced E-cadherin expression in non-
neoplastic acantholytic disorders of the skin8
and a study of adhesion molecule expression
in these sarcomatoid tumours would be of
interest.
Pseudoangiosarcomatous carcinoma seems
to behave in an aggressive manner reflecting
the high grade, poorly differentiated nature of
the carcinoma.?5 Angiosarcomas of the vulva
may, however, behave in a more indolent fash-
ion with recurrences and late metastases by
the haematogenous rather than the lymphatic
route.6
In conclusion, pseudoangiosarcomatous car-
cinoma should be considered in the differential
diagnosis of malignant angiomatoid tumours,
particularly those that arise at sites, like the
genitourinary tract, where angiosarcoma is rare.
Adequate sampling with careful examination
for keratinisation, atypical squamous epi-
thelium and areas of differentiated carcinoma
is advised and immunohistochemistry and pos-
sibly electron microscopy performed.
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Abstract
An uncommon case of undifferentiated
carcinoma of the gall bladder in a 65 year
old Chinese man, who presented with an
increased serum a-fetoprotein con-
centration, is reported. Histologically, the
tumour had a primitive appearance and
was composed ofa pavement-like array of
poorly differentiated columnar/polygonal
cells. Alpha-fetoprotein was demonstrated
in some of the tumour cells using an im-
munoperoxidase technique. Alpha-feto-
protein secretion in this instance may have
occurred because the gall bladder and the
liver are of similar embryological origin.
Alpha-fetoprotein may also be related to
the resurgent expression of oncofetal an-
tigens. This tumour may represent an-
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other rare cause of increased serum a-
fetoprotein concentrations.
(_J Clin Pathol 1995;48:1061-1063)
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Serum oa-fetoprotein concentrations are often
noticeably increased in hepatocellular car-
cinomas and yolk sac tumours. Such increases
have also rarely been associated with carcinoma
of the stomach,' colon, pancreas,2 and lung.3
Many gall bladder malignancies are mucin se-
creting adenocarcinomas and do not secrete a-
fetoprotein; however, a rare type of gall bladder
carcinoma, previously known as pleomorphic
giant cell adenocarcinoma, has been reported
to be associated with intra- and/or extracellular
oa-fetoprotein containing eosinophilic globules.'
Recently, Vardaman et al5 described seven cases
of clear cell carcinoma of the gall bladder.
76.
Figure 1 Photomicrograph of the gall bladder tumour showing the pavement-like array
of tumour cells (haematoxylin and eosin, original magnification x 400).
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Figure 2 Photomicrograph of immunohistochemical staining showing cytoplasmic
positivity for a-fetoprotein in some of the tumour cells (original magnification x 1000).
One of their cases showed features of hepatoid
differentiation and was associated with oa-feto-
protein secretion. Here, we report a rare case of
undifferentiated carcinoma of the gall bladder
presenting with persistently increased serum oa-
fetoprotein concentrations. The morphology of
this tumour, however, was different from that
of clear cell carcinoma.
Case report
A 65 year old Chinese man first presented with
epigastric pain of several days duration. On
admission, the patient had an increased total
bilirubin concentration (124 jtmol/l) and slight
derangement of liver function. His serum oa-
fetoprotein concentration was 32 ng/ml. Ul-
trasonogram of the biliary system and en-
doscopic retrograde cholangiopancreatogram
were unremarkable. Four months after pre-
sentation, the patient's serum oa-fetoprotein
concentration rose to 256 ng/ml. Liver function
remained normal. Hepatic arteriogram and
lipoidal computed tomography were performed
and did not reveal a definite tumour mass in
the liver. The gall bladder wall, however, was
thickened with a focal increase in density. The
patient's serum oa-fetoprotein concentration re-
mained high and was 425 ng/ml one month
later. Seven months after initial presentation,
the patient was readmitted because ofrecurrent
epigastric pain. His serum cx-fetoprotein con-
centration was 275 ng/ml at this time. The
patient died suddenly two days after admission
of cardiac failure.
A clinical postmortem examination was per-
formed one day after his death. There was a 4
cm, tan coloured, fungating tumour over the
fundus of the gall bladder. The distal part of
the common bile duct was obstructed by a 2
cm, cylindrical, necrotic tumour mass which
had detached from the main tumour bulk in
the gall bladder. Local destruction of adjacent
organs was not seen. Gallstones and lymph
node enlargement were not present. The liver
was mildly enlarged and there was no evidence
of hepatocellular carcinoma. Thorough ex-
amination of the testes, mediastinum and brain
revealed no evidence of germ cell tumours.
Multiple tissue blocks were sampled from
the gall bladder tumour, promptly fixed in 10%
neutral buffered formalin and embedded in
paraffin wax. Sections, 3 jtm thick, were cut
and stained with haematoxylin and eosin, mu-
cicarmine, periodic acid-Schiff (PAS), alcian
blue, Grimelius, and Fontana-Masson. Im-
munohistochemical studies were carried out
using the Streptavidin biotin complex tech-
nique using antibodies directed against cx-feto-
protein (Dako), AE 1/3 (BioGenex), Cam 5.2
(Becton Dickinson), vimentin (Dako), mono-
clonal carcinoembryonic antigen (Dako),
neuron-specific enolase (BioGenex), chro-
mogranin (BioGenex), and synaptophysin
(Boehringer Mannheim).
Histological examination of the gall bladder
tumour revealed a superficially invasive car-
cinoma infiltrating the inner part of the muscle
coat. The tumour was composed of a pave-
ment-like array of columnar/polygonal cells (fig
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1) which contained a moderately pleomorphic
vesicular nucleus, inconspicuous nucleoli, fre-
quent mitotic figures, and foamy to granular
amphophilic cytoplasm. Occasional tumour
giant cell formation was evident. There were
no sarcomatoid or clear cell changes. Focal
areas with a microtrabecular pattern and pal-
isaded nuclei were identified, but true papillary
configurations or hepatoid differentiation was
not found. In some of the sections the tumour
cells were associated with clumps of acellu-
lar eosinophilic squame-like material. True
squamous cell components, however, were not
identified. The tumour cells were negative for
mucicarmine, PAS and alcian blue. They were
also non-argyrophilic and non-argentaffinic.
On immunohistochemistry, oa-fetoprotein was
detected in the cytoplasm of some tumour
cells (fig 2) as well as among extracellular
eosinophilic material. The tumour cells did not
express vimentin, carcinoembryonic antigen,
neuron-specific enolase, chromogranin, or sy-
naptophysin.
Discussion
Alpha-fetoprotein is a serum glycoprotein pro-
duced by embryonic liver cells and yolk sac
tissues. It has no confirmed biological function
in humans. The serum oa-fetoprotein con-
centration is of particular value in the diagnosis
and follow up of hepatocellular carcinomas or
yolk sac tumours. It has been proposed that a
serum concentration of400 ng/m in adults may
be a useful threshold for diagnosing hepa-
tocellular carcinoma. Other tumour types and
non-neoplastic conditions such as viral hep-
atitis and inflammatory bowel disease are rarely
associated with this degree of elevation. This
patient represents a rare case of carcinoma of
gall bladder associated with a persistent in-
crease in serum oa-fetoprotein concentrations.
Histologically, the tumour was an un-
differentiated carcinoma of the gall bladder,
previously referred to as pleomorphic giant cell
adenocarcinoma. This group of neoplasms is
characterised by a wide spectrum of mor-
phology and various proportions of polygonal,
round, spindle, and multinucleated giant cells.4
Areas of well differentiated adenocarcinoma
are found in about two thirds of the tumours,
representing a transition from pleomorphic
components to well differentiated elements.
Foci of squamoid differentiation may also be
present in a small number of cases. The final
third, including the case presented here, con-
sists exclusively of undifferentiated elements.
Eosinophilic hyaline globules are present in
about 10% of the tumours, and some are posi-
tive for oa-1-antitrypsin or ca-fetoprotein. The
wide spectrum ofmorphological features ofthis
group of tumours illustrates their potential to
differentiate along different lines including
glandular, squamous and hepatoid. In contrast
to most of the previously reported cases of
oa-fetoprotein producing gall bladder car-
cinomas,5" this case did not show any evidence
of clear cell differentiation. It is possible that
the present case and the a-fetoprotein secreting
clear cell carcinomas simply represent two ex-
tremes of a spectrum with different degrees
and stages of hepatoid differentiation.
Secretion of ot-fetoprotein by gall bladder
carcinomas may occur because the gall bladder
and the liver are of similar embryological origin,
as well as because ofthe resurgence ofoncofetal
antigens. Embryologically, the gall bladder ori-
ginates from the hepatic diverticulum, which
is a ventral outgrowth from the caudal part of
the foregut and later divides to form the gall
bladder and the liver. In laboratory animals
chemically induced liver tumours can differ-
entiate morphologically and biochemically
towards either liver tissues or intestinal epi-
thelium.'0 Similarly, because the gall bladder
and the liver are closely related at the em-
bryological level, multipotential uncommitted
tumour cells in undifferentiated carcinoma of
the gall bladder may undergo primitive hepa-
toid differentiation and acquire the ability to
produce a-fetoprotein. Alternatively, re-
surgence of oncofetal antigen expression by the
tumour cells may also explain this phe-
nomenon.
The present case represents another
uncommon cause of increased serum oa-
fetoprotein concentrations. While this phe-
nomenon may help in the understanding of
embryological differentiation of undiffer-
entiated gall bladder carcinomas, it may also
serve to remind clinicians that increased serum
oa-fetoprotein concentrations in adults are not
always diagnostic of hepatocellular carcinoma.
Analysis of follow up serum oa-fetoprotein con-
centrations can also be useful for assessing
tumour recurrence.
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